Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 951 to 1000 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
476\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5067.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859.44\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859.17\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5926.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5066.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859.11\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8029.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7170.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
858.81\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5925.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5066.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
858.45\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
857.09\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
857.09\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s28. [source:swissprot;acc:p25112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8015.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7161.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
854.78\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7994.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7139.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
854.56\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1027.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1881.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
853.66\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6826.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5975.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
851.13\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
12491.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10908.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14513\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6042.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5277.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14505\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek2 (ec 2.7.1.37) (nima-related protein kinase 2) (nima-like protein kinase 1) (hspk 21). [source:swissprot;acc:p51955]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6826.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5975.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
851.13\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10872.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14483\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7953.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7105.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
848.44\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7949.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7101.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
847.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6044.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5281.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14457\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7949.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7101.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
847.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
13346.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15274.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14445\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6843.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5980.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7909.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7067.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
841.81\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
492\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6842.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5979.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14429\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
839.77\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
493\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6842.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5979.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14429\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
494\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
e2a-pbx1-associated protein; putative 47 kda protein. [source:refseq;acc:nm\_020140]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6842.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5979.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14428\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
839.77\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
495\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12363.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10804.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14428\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
496\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
839.77\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
497\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5554.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4714.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
839.53\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
498\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7766.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6933.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
833.37\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
499\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7770.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6938.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
832.43\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
500\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein 1 (hip-i). [source:swissprot;acc:o00291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9902.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
830.8\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/